FluoretiQ Limited

We develop diagnostics that are fast, accurate and can be used at the point of care: ensuring the first prescription, is always the right prescription. Our technologies answer 2 vital questions to ensure effective and sustainable use of antibiotics: Does the patient have an infection treatable with antibiotics? NANOPLEX is an advanced latex agglutination test that can be used to rapidly identify and quantify the cause of infection in 5 minutes. What will be the most effective antibiotic treatment? SCFITM is a phenotypic, real-time and growth-free antibiotic susceptibility test that determines the most effective antibiotic in 30 minutes

Synthetic chemistry,microbiology,antimicrobial resistance,antibiotic stewardship,diagnostics,and rapid testing

Fluoretiq limited operates in the Medical equipment manufacturing industry.

Fluoretiq limited's revenue is 1m - 10m

Fluoretiq limited has 11 - 50 employees.